Inhibition of the P2X7 receptor reduces cystogenesis in PKD

Ming Yang Chang, Jenn Kan Lu, Ya Chung Tian, Yung Chang Chen, Cheng Chieh Hung, Yi Hui Huang, Yau Hung Chen, Mai Szu Wu, Chih Wei Yang, Yi Chuan Cheng

研究成果: 雜誌貢獻文章

33 引文 斯高帕斯(Scopus)

摘要

The P2X7 receptor participates in purinergic signaling, which may promote the progression of ADPKD. We examined the effects of a P2X7 receptor antagonist and a P2X7 receptor agonist on cyst development in a zebrafish model of polycystic kidney disease in which we knocked down pkd2 by morpholinos. We used live wt-1b pronephric-specific GFP-expressing zebrafish embryos to directly observe changes in the pronephros. Exposure of pkd2-morphant zebrafish to a P2X7 receptor antagonist (oxidized ATP [OxATP]) significantly reduced the frequency of the cystic phenotype compared with either exposure to a P2X7 receptor agonist (BzATP) or with no treatment (P < 0.01). Histology confirmed improvement of glomerular cysts in OxATP-treated pkd2 morphants. OxATP also reduced p-ERK activity and cell proliferation in pronephric kidneys in pkd2 morphants. Inhibition of P2X7 with an additional specific antagonist (A-438079), and through morpholino-mediated knockdown of p2rx7, confirmed these effects. In conclusion, blockade of the P2X7 receptor reduces cyst formation via ERK-dependent pathways in a zebrafish model of polycystic kidney disease, suggesting that P2X7 antagonists may have therapeutic potential in ADPKD.

原文英語
頁(從 - 到)1696-1706
頁數11
期刊Journal of the American Society of Nephrology
22
發行號9
DOIs
出版狀態已發佈 - 九月 2011

ASJC Scopus subject areas

  • Nephrology

指紋 深入研究「Inhibition of the P2X7 receptor reduces cystogenesis in PKD」主題。共同形成了獨特的指紋。

  • 引用此

    Chang, M. Y., Lu, J. K., Tian, Y. C., Chen, Y. C., Hung, C. C., Huang, Y. H., Chen, Y. H., Wu, M. S., Yang, C. W., & Cheng, Y. C. (2011). Inhibition of the P2X7 receptor reduces cystogenesis in PKD. Journal of the American Society of Nephrology, 22(9), 1696-1706. https://doi.org/10.1681/ASN.2010070728